close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Virpax Pharmaceuticals Inc/

Recent news which mentions Virpax Pharmaceuticals Inc/

Lab Notes: AnPac dips into real estate with diversification strategy; Mineralys closes $220.8M IPO
Tickers INNO
Tags Children's Hospital Of Philadelphia Haohan Xu Biotech
From Business Journals
Lab Notes: FMC enters into a $200M bio-acquisition; Virpax going the OTC route again
Tickers INNO
Tags Irina Borodina Stuart Lutzker Biotech
From Business Journals
Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
Tickers INNO
Tags Pharmaceuticals Inno Health Care
From Business Journals
Lab Notes: Helius launches flagship product in U.S.; Virpax reports positive preclinical results for seizure drug
Tickers INNO
Tags Helius Medical Technologies Inc/ (DE) Roundup Virpax Pharmaceuticals Inc/
From Business Journals
Virpax shares rise on expanded licensing deal for experimental drug
Tags Pharmaceuticals Biotech Christopher M/ Chipman
From Business Journals
Lab Notes: LIMR awarded research grant; Virpax posts positive study results for pain treatment
Tickers INNO
Tags Health Care Insurance Pharmaceuticals
From Business Journals
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
Tickers INNO
Tags Biotech Pharmaceuticals Vallon Pharmaceuticals Inc/
From Business Journals
Lab Notes: Arbutus and Penn make headway on Covid-19 treatments; Carisma partners with Merck
Tickers INNO
Tags Arbutus Biopharma Corporation Michael Sofia Joseph Truitt
From Business Journals
Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
Tickers INNO
Tags Jean/Pierre Issa Anthony P/ Mack Virpax Pharmaceuticals Inc/
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today